Butyrate enhances antibacterial effects while suppressing other features of alternative activation in IL-4-induced macrophages

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 310, Issue 10, 2016, Pages G822-G831

  Fernando, Maria R ^a   Saxena, Alpana ^a   Reyes, José Luis ^a   McKay, Derek M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Innate immunity; Intestinal homeostasis; Microbiota

Indexed keywords

ACETIC ACID; ARGINASE 1; BUTYRIC ACID; CHITINASE LIKE 3 PROTEIN; HISTONE; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROPIONIC ACID; PROTEIN; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; ARG1 PROTEIN, MOUSE; ARGINASE; BETA N ACETYLHEXOSAMINIDASE; BUTYRIC ACID DERIVATIVE; CHI3L3 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 12; LECTIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CELL ACTIVATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEACETYLATION; ENZYME ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HOMEOSTASIS; HOST; MACROPHAGE; MACROPHAGE MIGRATION; MIGRATION INHIBITION; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; DRUG EFFECTS; GENETICS; IMMUNOLOGY; MACROPHAGE ACTIVATION; MALE; METABOLISM;

ANIMALS; ARGINASE; BETA-N-ACETYLHEXOSAMINIDASES; BUTYRATES; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; LECTINS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; T-LYMPHOCYTES, REGULATORY;

EID: 84984608940     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00440.2015     Document Type: Article

References (41)

1. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504: 451–455, 2013.
2. Bordonaro M, Drago E, Atamna W, Lazarova DL. Comprehensive suppression of all apoptosis-induced proliferation pathways as a proposed approach to colorectal cancer prevention and therapy. PLoS One 9: e115068, 2014.
3. Campbell L, Emmerson E, Williams H, Saville CR, Krust A, Chambon P, Mace KA, Hardman MJ. Estrogen receptor-α promotes alternative macrophage activation during cutaneous repair. J Invest Dermatol 134: 2447–2457, 2014.
4. Campbell L, Saville CR, Murray PJ, Cruickshank SM, Hardman MJ. Local arginase 1 activity is required for cutaneous wound healing. J Invest Dermatol 133: 2461–2470, 2013.
5. Chang PV, Hao L, Offermanns S, Medzhitov R. The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111: 2247–2252, 2014.
6. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 10: 735–742, 2012.
7. Donohoe DR, Collins LB, Wali A, Bigler R, Sun W, Bultman SJ. The Warburg effect dictates the mechanism of butyrate-mediated histone acetylation and cell proliferation. Mol Cell 48: 612–626, 2012.
8. DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol 8: 523–531, 2011.
9. Farache J, Zigmond E, Shakhar G, Jung S. Contributions of dendritic cells and macrophages to intestinal homeostasis and immune defense. Immunol Cell Biol 91: 232–239, 2013.
10. Fernando MR, Reyes JL, Iannuzzi J, Leung G, McKay DM. The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. PLoS One 9: e94188, 2014.
11. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504: 446–450, 2013.
12. Hague A, Butt AJ, Paraskeva C. The role of butyrate in human colonic epithelial cells: an energy source or inducer of differentiation and apoptosis? Proc Nutr Soc 55: 937–943, 1996.
13. Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 27: 104–119, 2008.
14. Hunter MM, Wang A, Parhar KS, Johnston MJ, van Rooijen N, Beck PL, McKay DM. In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138: 1395–1405, 2010.
15. Lewis K, Lutgendorff F, Phan V, Söderholm JD, Sherman PM, McKay DM. Enhanced translocation of bacteria across metabolicallystressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16: 1138–1148, 2010.
16. Ivanov II, Atarashi K, Manel N, Brodie EL, Shima T, Karaoz U, Wei D, Goldfarb KC, Santee CA, Lynch SV, Tanoue T, Imaoka A, Itoh K, Takeda K, Umesaki Y, Honda K, Littman DR. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139: 485–498, 2009.
17. Lührs H, Gerke T, Müller JG, Melcher R, Schauber J, Boxberge F, Scheppach W, Menzel T. Butyrate inhibits NF-κ B activation in lamina propria macrophages of patients with ulcerative colitis. Scand J Gastroenterol 37: 458–466, 2002.
18. Maa MC, Chang MY, Hsieh MY, Chen YJ, Yang CJ, Chen ZC, Li YK, Yen CK, Wu RR, Leu TH. Butyrate reduced lipopolysaccharidemediated macrophage migration by suppression of Src enhancement and focal adhesion kinase activity. J Nutr Biochem 21: 1186–1192, 2010.
19. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, Mege JL, Mosser DM, Natoli G, Saeij JP, Schultze JL, Shirey KA, Sica A, Suttles J, Udalova I, van Ginderachter JA, Vogel SN, Wynn TA. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14–20, 2014.
20. Natarajan N, Pluznick JL. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol 307: C979–C985, 2014.
21. Niks M, Otto M. Towards an optimized MTT assay. J Immunol Methods 130: 149–151, 1990.
22. Nishio J, Honda K. Immunoregulation by the gut microbiota. Cell Mol Life Sci 69: 3635–3650, 2012.
23. O’Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 7: 688–693, 2006.
24. Philpott DJ, McKay DM, Sherman PM, Perdue MH. Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. Am J Physiol Gastrointest Liver Physiol 270: G634–G645, 1996.
25. Rahman MM, Kukita A, Kukita T, Shobuike T, Nakamura T, Kohashi O. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 101: 3451–3459, 2003.
26. Rizzo A, Monteleone I, Fina D, Stolfi C, Caruso R, Fantini MC, Franzè E, Schwendener R, Pallone F, Monteleone G. Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages. Inflamm Bowel Dis 18: 449–459, 2012.
27. Roediger WE. Utilization of nutrients by isolated epithelial cells of the rat colon. Gastroenterology 83: 424–429, 1982.
28. Seno H, Miyoshi H, Brown SL, Geske MJ, Colonna M, Stappenbeck TS. Efficient colonic mucosal wound repair requires Trem2 signaling. Proc Natl Acad Sci USA 106: 256–261, 2009.
29. Serrat N, Pereira-Lopes S, Comalada M, Lloberas J, Celada A. Deacetylation of C/EBPβ is required for IL-4-induced arginase-1 expression in murine macrophages. Eur J Immunol 42: 3028–3037, 2012.
30. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40: 128–139, 2014.
31. Smythies LE, Sellers M, Clements RH, Mosteller-Barnum M, Meng G, Benjamin WH, Orenstein JM, Smith PD. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66–75, 2005.
32. Steinhart AH, Hiruki T, Brzezinski A, Baker JP. Treatment of leftsided ulcerative colitis with butyrate enemas: a controlled trial. Aliment Pharmacol Ther 10: 729–736, 1996.
33. Varin A, Mukhopadhyay S, Herbein G, Gordon S. Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115: 353–362, 2010.
34. Vrba J, Trtkova K, Ulrichova J. HDAC inhibitors sodium butyrate and sodium valproate do not affect human ncor1 and ncor2 gene expression in HL-60 cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 155: 259–262, 2011.
35. Wang X, Liu Y, Chen X, Zhang M, Xiao Z. Impact of MiR-21 on the expression of FasL in the presence of TGF-β 1. Aesthet Surg J 33: 1186–1198, 2013.
36. Wedlake L, Slack N, Andreyev HJ, Whelan K. Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. Inflamm Bowel Dis 20: 576–586, 2014.
37. Weischenfeldt J, Porse B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc 2008: pdb.prot5080 –pdb-.prot5080, 2008.
38. Weisser SB, Brugger HK, Voglmaier NS, McLarren KW, van Rooijen N, Sly LM. SHIP-deficient, alternatively activated macrophages protect mice during DSS-induced colitis. J Leukoc Biol 90: 483–492, 2011.
39. Weisser SB, Kozicky LK, Brugger HK, Ngoh EN, Cheung B, Jen R, Menzies SC, Samarakoon A, Murray PJ, Lim CJ, Johnson P, Boucher JL, van Rooijen N, Sly LM. Arginase activity in alternatively activated macrophages protects PI3Kp110δ deficient mice from dextran sodium sulfate induced intestinal inflammation. Eur J Immunol 44: 3353–3367, 2014.
40. Zigmond E, Jung S. Intestinal macrophages: well educated exceptions from the rule. Trends Immunol 34: 162–168, 2013.
41. Zuo L, Lu M, Zhou Q, Wei W, Wang Y. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol 62: 892–900, 2013.